Unplanned hospital readmissions in Massachusetts represent a significant cost, not only to the health system but to patients and their families, according to the findings in a Center for Health Information and Analysis report on unplanned hospital readmissions in Massachusetts.
Interoperability continues to improve among hospitals, according to the Office of the National Coordinator for Health Information. As of 2021, 88% of hospitals engaged in electronically sending and obtaining patient health information, through either querying or electronically receiving summary of care records.
The National Institutes of Health will award $3,906,026 over five years to researchers from the Institute for Implementation Science in Population Health (ISPH) at the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) to test the efficacy of a new socialization and sex education curriculum for young people with intellectual and developmental […]
In honor of Black History Month, healthcare leaders highlight Black American accomplishments.
Another insurer has finalized a large acquisition. Who’s the buyer, and what did they get? We’ll touch on that and other topics in this week’s Top Stories, including the privacy of data on wearable devices, and an opportunity for doctors to weigh in on AI-powered prodct development. For more news and features from Jeff Lagasse, […]
Vin Phan is a partner and practice leader of BDO’s National Healthcare Transaction Advisory Services practice. He works with companies on financial due diligence, including M&A transactions.
Former Cigna executive Amy Bricker is being temporarily blocked from beginning her new job at CVS Health, pending the outcome of a lawsuit over Cigna’s noncompete agreement, according to a restraining order filed in a Missouri district court.
Humana has said it will be exiting the Employer Group Commercial Medical Products business, which includes all fully insured, self-funded and Federal Employee Health Benefit medical plans, as well as associated wellness and rewards programs.
Partner at GSR Ventures Dr. Sunny Kumar, talks about priorities, interest areas, investing and the distinction between tech-enabled and tech services.
The Centers for Medicare and Medicaid Services is not reconsidering the national coverage determination for Food and Drug Administration (FDA)-approved medications for Alzheimer’s disease. The FDA-approved monoclonal antibodies are directed against amyloid, or the protein buildup, for the treatment of Alzheimer’s disease.